News

Vasa Therapeutics Partners with Eli Lilly's TuneLab AI Platform for CAMKII Inhibitor Development

2 min

SynuSight Biotech's SST001 Alpha-Synuclein PET Tracer Receives NMPA Approval for Phase I Clinical Trial

2 min

Oryon Cell Therapies Appoints Dr. Burkhard Blank as Chief Medical Officer to Lead Clinical Development

2 min

Amneal Pharmaceuticals Launches First Respiratory Inhalers: Albuterol and Beclomethasone HFA Products Now Available

2 min

Bright Path Applauds President's FY2027 Budget for Domestic Pharmaceutical Manufacturing Investment

2 min

FDA Approves BIZENGRI (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma

FDA · 2 min

Clearmind Medicine's CMND-100 Meets Primary Endpoint in Phase I/IIa Trial for Alcohol Use Disorder

FDA · Alcohol Use Disorder (AUD) · 3 min

FDA Accepts Praxis Precision Medicines' New Drug Application for Ulixacaltamide HCl Essential Tremor Treatment

FDA · 2 min

FDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease

FDA · Nephrology - Focal Segmental Glomerulosclerosis (FSGS) · 4 min

Apotex Receives FDA Approval for First Generic Infuvite Adult Injection with 180-Day Exclusivity

FDA · 2 min

FDA Approves RARE-Cure’s Orphan Drug Enzyme Replacement Therapy

FDA · Rare Metabolic Disorders · 5 min

FDA Approves MigraEase: Faster Relief Migraine Drug Launch

FDA · Neurology · 7 min